June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Modulation of Transgene Expression in Retinal Gene Therapy by Selective Laser Treatment
Author Affiliations & Notes
  • Daniel Lavinsky
    Ophthalmology, Federal Univesity of Rio Grande do Sul, Porto Alegre, Brazil
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Thomas Chalberg
    Avalanche Biotechnologies, San Francisco, CA
  • Yossi Mandel
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Philip Huie
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Roopa Dalal
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Michael Marmor
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Daniel Palanker
    Ophthalmology and HEPL, Stanford University, Stanford, CA
  • Footnotes
    Commercial Relationships Daniel Lavinsky, TMLS (C); Thomas Chalberg, Avalanche Biotechnologies, Inc. (E), Avalanche Biotechnologies, Inc. (I), Avalanche Biotechnologies, Inc. (P), Avalanche Biotechnologies, Inc. (S); Yossi Mandel, None; Philip Huie, None; Roopa Dalal, None; Michael Marmor, Basilea (C), Cordera (C), Corcept (C), Acucela (C), Merck (C); Daniel Palanker, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4132. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Daniel Lavinsky, Thomas Chalberg, Yossi Mandel, Philip Huie, Roopa Dalal, Michael Marmor, Daniel Palanker; Modulation of Transgene Expression in Retinal Gene Therapy by Selective Laser Treatment. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4132. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To develop a method for modulation of transgene expression in retinal pigment epithelium (RPE) using scanning laser which spares neurosensory retina.

Methods: Fifteen pigmented rabbits received subretinal injection of rAAV-2 encoding green fluorescent protein (GFP). GFP expression was measured using cSLO fluorescence imaging and immunohistochemistry. To reduce the total expression in RPE by half, 50% of the transfected RPE cells were selectively destroyed by microsecond exposures to scanning laser with 50% pattern density. The selectivity of RPE destruction and its migration and proliferation was monitored using fluorescein angiography, SD-OCT, light, transmission and scanning electron microscopy. BrdU assay was performed to evaluate proliferation of RPE cells.

Results: RPE cells were selectively destroyed by the line scanning laser with 15μs exposures, without damage to the photoreceptors or Bruch’s membrane. RPE cells started migrating after the first day, and in one week there was complete restoration of RPE monolayer. Selective laser treatment decreased the GFP fluorescence by 54% as compared to control areas; this was further decreased by an additional 48% following a second treatment one month later. BrdU assay demonstrated proliferation in approximately half of the RPE cells in treatment areas.

Conclusions: Microsecond exposures produced by scanning laser destroyed RPE cells selectively, without damage to neural retina. Continuity of RPE layer is restored within days by migration and proliferation, but transgene not integrated into the nucleus is not replicated. Therefore, gene expression can be modulated in a precise manner by controlling the laser pattern density, and further adjusted using repeated applications.

Keywords: 538 gene transfer/gene therapy • 578 laser • 701 retinal pigment epithelium  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×